154 related articles for article (PubMed ID: 36261755)
21. Modelling and understanding powder flow properties and compactability of selected active pharmaceutical ingredients, excipients and physical mixtures from critical material properties.
Worku ZA; Kumar D; Gomes JV; He Y; Glennon B; Ramisetty KA; Rasmuson ÅC; O'Connell P; Gallagher KH; Woods T; Shastri NR; Healy AM
Int J Pharm; 2017 Oct; 531(1):191-204. PubMed ID: 28801109
[TBL] [Abstract][Full Text] [Related]
22. Tableting process optimisation with the application of fuzzy models.
Belic A; Skrjanc I; Bozic DZ; Vrecer F
Int J Pharm; 2010 Apr; 389(1-2):86-93. PubMed ID: 20096760
[TBL] [Abstract][Full Text] [Related]
23. Curating gene sets: challenges and opportunities for integrative analysis.
Bubier J; Hill D; Mukherjee G; Reynolds T; Baker EJ; Berger A; Emerson J; Blake JA; Chesler EJ
Database (Oxford); 2019 Jan; 2019():. PubMed ID: 30888410
[TBL] [Abstract][Full Text] [Related]
24. Prediction of bulk powder flow performance using comprehensive particle size and particle shape distributions.
Yu W; Muteki K; Zhang L; Kim G
J Pharm Sci; 2011 Jan; 100(1):284-93. PubMed ID: 20572055
[TBL] [Abstract][Full Text] [Related]
25. Improvement of flow and bulk density of pharmaceutical powders using surface modification.
Jallo LJ; Ghoroi C; Gurumurthy L; Patel U; Davé RN
Int J Pharm; 2012 Feb; 423(2):213-25. PubMed ID: 22197769
[TBL] [Abstract][Full Text] [Related]
26. Understanding the Factors That Control the Quality of Mini-Tablet Compression: Flow, Particle Size, and Tooling Dimension.
Zhao J; Yin D; Rowe J; Badawy S; Nikfar F; Pandey P
J Pharm Sci; 2018 Apr; 107(4):1204-1208. PubMed ID: 29233726
[TBL] [Abstract][Full Text] [Related]
27. Characterization of Metal Powders Used for Additive Manufacturing.
Slotwinski JA; Garboczi EJ; Stutzman PE; Ferraris CF; Watson SS; Peltz MA
J Res Natl Inst Stand Technol; 2014; 119():460-93. PubMed ID: 26601040
[TBL] [Abstract][Full Text] [Related]
28. Characterization of particle sizes in bulk pharmaceutical solids using digital image information.
Laitinen N; Antikainen O; Yliruusi J
AAPS PharmSciTech; 2003 Oct; 4(4):E49. PubMed ID: 15198544
[TBL] [Abstract][Full Text] [Related]
29. Manufacturing classification system in the real world: factors influencing manufacturing process choices for filed commercial oral solid dosage formulations, case studies from industry and considerations for continuous processing.
Leane M; Pitt K; Reynolds GK; Dawson N; Ziegler I; Szepes A; Crean AM; Dall Agnol R; The Manufacturing Classification System McS Working Group
Pharm Dev Technol; 2018 Dec; 23(10):964-977. PubMed ID: 30320539
[TBL] [Abstract][Full Text] [Related]
30. Application of image-based particle size and shape characterization systems in the development of small molecule pharmaceuticals.
Gamble JF; Tobyn M; Hamey R
J Pharm Sci; 2015 May; 104(5):1563-74. PubMed ID: 25690940
[TBL] [Abstract][Full Text] [Related]
31. Low powder mass filling of dry powder inhalation formulations.
Eskandar F; Lejeune M; Edge S
Drug Dev Ind Pharm; 2011 Jan; 37(1):24-32. PubMed ID: 20738180
[TBL] [Abstract][Full Text] [Related]
32. Particle engineering in pharmaceutical solids processing: surface energy considerations.
Williams DR
Curr Pharm Des; 2015; 21(19):2677-94. PubMed ID: 25876912
[TBL] [Abstract][Full Text] [Related]
33. Continuous manufacturing of extended release tablets via powder mixing and direct compression.
Ervasti T; Simonaho SP; Ketolainen J; Forsberg P; Fransson M; Wikström H; Folestad S; Lakio S; Tajarobi P; Abrahmsén-Alami S
Int J Pharm; 2015 Nov; 495(1):290-301. PubMed ID: 26320548
[TBL] [Abstract][Full Text] [Related]
34. Feeding of particle-based materials in continuous solid dosage manufacturing: a material science perspective.
Hsiao WK; Hörmann TR; Toson P; Paudel A; Ghiotti P; Stauffer F; Bauer F; Lakio S; Behrend O; Maurer R; Holman J; Khinast J
Drug Discov Today; 2020 Apr; 25(4):800-806. PubMed ID: 31982395
[TBL] [Abstract][Full Text] [Related]
35. Dropwise Additive Manufacturing of Pharmaceutical Products Using Particle Suspensions.
Radcliffe AJ; Hilden JL; Nagy ZK; Reklaitis GV
J Pharm Sci; 2019 Feb; 108(2):914-928. PubMed ID: 30308177
[TBL] [Abstract][Full Text] [Related]
36. [Revealing the essence of powders: from the base to the application].
Sunada H
Yakugaku Zasshi; 2008 Aug; 128(8):1087-107. PubMed ID: 18670175
[TBL] [Abstract][Full Text] [Related]
37. Particle Engineering of Excipients for Direct Compression: Understanding the Role of Material Properties.
Mangal S; Meiser F; Morton D; Larson I
Curr Pharm Des; 2015; 21(40):5877-89. PubMed ID: 26446468
[TBL] [Abstract][Full Text] [Related]
38. Process simulation in the pharmaceutical industry: a review of some basic physical models.
Kremer DM; Hancock BC
J Pharm Sci; 2006 Mar; 95(3):517-29. PubMed ID: 16447175
[TBL] [Abstract][Full Text] [Related]
39. Modeling and simulation of continuous powder blending applied to a continuous direct compression process.
Galbraith SC; Liu H; Cha B; Park SY; Huang Z; Yoon S
Pharm Dev Technol; 2018 Dec; 23(10):1097-1107. PubMed ID: 29304722
[TBL] [Abstract][Full Text] [Related]
40. PQRI recommendations on particle-size analysis of drug substances used in oral dosage forms.
Snorek SM; Bauer JF; Chidambaram N; Doub WH; Duffy EP; Etzler FM; Kelly RN; Lane JJ; Mueller RL; Prasanna HR; Pujara CP; Reif VD; Scarlett B; Stowell JG; Toma PH
J Pharm Sci; 2007 Jun; 96(6):1451-67. PubMed ID: 17238204
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
